Mesoblast (MESO) News Today → The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad) Free MESO Stock Alerts $5.21 +0.10 (+1.96%) (As of 05:21 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineMesoblast (NASDAQ:MESO) Stock Price Up 7.9%marketbeat.com - April 17 at 12:20 PMInsiders are buying Mesoblast and these ASX sharesmsn.com - April 16 at 9:41 AMMesoblast (NASDAQ:MESO) Shares Down 2.9% americanbankingnews.com - April 13 at 6:00 AMMesoblast Limited (NASDAQ:MESO) Given Consensus Rating of "Hold" by Brokeragesamericanbankingnews.com - April 12 at 2:20 AMMesoblast Limited (NASDAQ:MESO) Given Consensus Recommendation of "Hold" by Brokeragesmarketbeat.com - April 12 at 2:17 AMMesoblast Limited (NASDAQ:MESO) Sees Large Growth in Short Interestmarketbeat.com - April 12 at 12:14 AMMesoblast Limited: Back From The Deadseekingalpha.com - April 10 at 1:29 PMMesoblast (NASDAQ:MESO) Shares Gap Down to $6.29marketbeat.com - April 9 at 11:25 AMMesoblast (NASDAQ:MESO) Shares Gap Up to $5.80marketbeat.com - April 8 at 11:36 AMWhy is everyone talking about Mesoblast shares?msn.com - April 5 at 5:37 PMMesoblast (NASDAQ:MESO) Stock Price Down 3.5%marketbeat.com - April 4 at 2:25 PMSpinal Fusion Pipeline Report 2024, Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companiesfinance.yahoo.com - April 4 at 11:34 AMFed members back cutting rates this year, but need confidence inflation slowingmsn.com - April 3 at 1:58 PMFeeling Bold? 3 Aggressive Plays to 10X Your Returns by 2025investorplace.com - April 3 at 7:00 AMTop ASX Stocks for this Monthau.investing.com - April 3 at 3:57 AMMesoblast (NASDAQ:MESO) Lowered to Sell at StockNews.commarketbeat.com - April 2 at 11:12 PMMesoblast share price dumps 10% as excitement simmers on FDA submissionfool.com.au - April 2 at 10:57 PMWhat is next for Tesla stock after soft Q1 sales reportau.investing.com - April 2 at 12:55 PMMesoblast (NASDAQ:MESO) Trading Up 6.6%marketbeat.com - April 2 at 12:51 PMBlast off! Mesoblast share price surging 60%fool.com.au - April 1 at 9:54 PMMesoblast (NASDAQ:MESO) Sees Strong Trading Volumemarketbeat.com - April 1 at 2:01 PMTop ASX shares to buy in April 2024fool.com.au - March 31 at 1:58 PMAohua receives Endoscopy Award at Healthcare Asia Medtech Awards 2024finance.yahoo.com - March 29 at 4:54 PMMesoblast Ltd LWBmorningstar.com - March 28 at 8:38 PMMesoblast (NASDAQ:MESO) Shares Gap Up to $3.49marketbeat.com - March 28 at 8:23 PMmarketbeat.com - March 28 at 9:39 AMASX retreats ahead of CPI; Mesoblast soars 45pcafr.com - March 27 at 10:27 AMiBio, ImmunityBio, Mesoblast among healthcare moversmsn.com - March 27 at 10:27 AMFDA Commentary Sends Biotech Soaring During Premarket Hoursmsn.com - March 26 at 10:00 AMMesoblast Shares Jump After FDA Nod for Submission of Remestemcel-L Applicationmarketwatch.com - March 26 at 10:00 AMMesoblast share price rockets 36% on breaking FDA newsfool.com.au - March 26 at 12:00 AMASX slips as tech declines; Mesoblast soars 47pcafr.com - March 26 at 12:00 AMFDA Indicates Adequate Data For Mesoblast's Remestemcel-L BLA Submission In Children With SR-aGVHDmarkets.businessinsider.com - March 26 at 12:00 AMUnited States Food & Drug Administration (FDA) Notifies Mesoblast that Available Clinical Data from Phase 3 Trial Appear Sufficient to Support BLA Submission for Remestemcel-L in Children with Steroid-Refractory Acute Graft Versus Host Disease (SR-aGVHD)globenewswire.com - March 25 at 10:34 PMMESO Jan 2025 0.500 callfinance.yahoo.com - March 20 at 4:33 AMMESO Oct 2024 2.000 callfinance.yahoo.com - March 19 at 6:32 PMMESO Jul 2024 2.000 putfinance.yahoo.com - March 19 at 6:32 PMMesoblast Limited (NASDAQ:MESO) Receives Average Recommendation of "Hold" from Brokeragesmarketbeat.com - March 18 at 2:23 AMMesoblast Successfully Completes Placement and Accelerated Entitlement Offerglobenewswire.com - March 13 at 7:30 PMWhy Is Cell Therapy Focused-Mesoblast Stock Trading Higher On Monday?msn.com - March 11 at 3:22 PMMesoblast Stock Rises 21% After FDA Feedbackmarketwatch.com - March 11 at 10:22 AMWhy 4DMedical, Block, Judo, and Mesoblast shares are pushing higher todayfool.com.au - March 10 at 9:55 PMUnited States Food & Drug Administration (FDA) Supports Accelerated Approval Pathway for Rexlemestrocel-L in End-Stage Heart Failure Patients with a Left Ventricular Assist Device (LVAD)globenewswire.com - March 10 at 7:54 PMWhy Cettire, GQG, Mesoblast, and Nine Entertainment shares are falling todayfool.com.au - March 7 at 9:23 PMMesoblast Limited (NASDAQ:MESO) Q2 2024 Earnings Call Transcriptfinance.yahoo.com - March 3 at 12:35 PMMesoblast Limited (NASDAQ:MESO) Q2 2024 Earnings Call Transcriptfinance.yahoo.com - March 3 at 12:35 PMMesoblast Limited (MESO) Q2 2024 Earnings Call Transcriptseekingalpha.com - March 2 at 10:43 AMMesoblast Limited 2024 Q2 - Results - Earnings Call Presentationseekingalpha.com - February 29 at 5:10 PMMesoblast First Half 2024 Earnings: EPS Beats Expectations, Revenues Lagfinance.yahoo.com - February 29 at 4:16 PMMesoblast share price tumbles on US$32.5m half-year lossfool.com.au - February 28 at 10:38 PM Get Mesoblast News Delivered to You Automatically Sign up to receive the latest news and ratings for MESO and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden’s $374B Giveaway Into This Sector (Ad)Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here Click here for the full story MESO Media Mentions By Week MESO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MESO News Sentiment▼0.290.52▲Average Medical News Sentiment MESO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MESO Articles This Week▼32▲MESO Articles Average Week Get Mesoblast News Delivered to You Automatically Sign up to receive the latest news and ratings for MESO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: FATE News Today ALLO News Today NVAX News Today HLVX News Today CGEM News Today EXAI News Today PRME News Today TRML News Today ALEC News Today EDIT News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MESO) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIHe Is Giving Away BitcoinCrypto Swap ProfitsSHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingHow Biden has already won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mesoblast Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.